Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting. Information about CHAC and the meeting can be found on the CHAC website at https://www.cdc.gov/faca/committees/chachspt.html and the meeting website at https://targethiv.org/events/chac.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 144 (Friday, July 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 144 (Friday, July 26, 2024)]
[Notices]
[Pages 60643-60644]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-16504]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis, and STD Prevention and Treatment
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Centers for Disease Control and Prevention
(CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHAC) has scheduled a public meeting.
Information about CHAC and the meeting can be found on the CHAC website
at <a href="https://www.cdc.gov/faca/committees/chachspt.html">https://www.cdc.gov/faca/committees/chachspt.html</a> and the meeting
website at <a href="https://targethiv.org/events/chac">https://targethiv.org/events/chac</a>.
DATES: October 21, 2024, 9 a.m. to 5 p.m. eastern time (ET) and October
22, 2024, 9 a.m. to 3 p.m. ET.
ADDRESSES: This meeting will be hybrid, held both virtually through
Zoom and in-person at 5600 Fishers Lane in Rockville, Maryland, 20857.
Advance registration is required to attend. Please visit the meeting
website to register. Registration will open in August. The in-person
registration deadline is
[[Page 60644]]
Monday, October 14, 2024, at 5 p.m. ET; registration for virtual
attendance will remain open. Prior to the meeting, each individual
registrant will receive a registration confirmation along with an
access link to the virtual meeting location.
FOR FURTHER INFORMATION CONTACT: Breana Alsworth, Public Health
Analyst, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland
20857; (301) 443-1134; or <a href="/cdn-cgi/l/email-protection#d19299909290b5a7b8a2bea3a892bebcbc91b9a3a2b0ffb6bea7"><span class="__cf_email__" data-cfemail="cd8e858c8e8ca9bba4bea2bfb48ea2a0a08da5bfbeace3aaa2bb">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: CHAC provides advice and recommendations to
the Secretary of HHS on policy, program development, and other matters
of significance concerning the activities under section 222 of the
Public Health Service Act, 42 U.S.C. 217a.
The purpose of CHAC is to advise the Secretary of HHS, CDC
Director, and HRSA Administrator regarding objectives, strategies,
policies, and priorities for the prevention and treatment of HIV, viral
hepatitis, and other STDs, including surveillance, epidemiologic,
behavioral, health services, and laboratory research, identification of
policy issues related to professional education, patient healthcare
delivery, and prevention services; agency policies regarding health
care delivery, research and training; strategic issues influencing the
ability of CDC and HRSA to fulfill their missions' programmatic efforts
to prevent and treat HIV, viral hepatitis, and other STDs; and support
to CDC and HRSA in their development of responses to emerging health
needs related to these issues.
During the October 21-22, 2024, meeting, CHAC will discuss issues
related to re-engaging people with HIV out of care (including data-to-
care strategies and overcoming barriers to care), the use of long-
acting injectables for HIV care and treatment and increasing access to
mental health services for people with HIV and STDs. Agenda items are
subject to change as priorities dictate. Please refer to the CHAC
meeting information page listed above for any updated meeting
information.
Members of the public will have the opportunity to provide
comments. Public participants may also submit written statements as
further described below. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to CHAC should be sent
via the meeting website at <a href="https://targethiv.org/events/chac">https://targethiv.org/events/chac</a> after
registration has opened. Requests for oral comment must be received by
October 11, 2024, at 5:00 p.m. ET to be considered. Written comments
may be submitted to Breana Alsworth (<a href="/cdn-cgi/l/email-protection#f4b7bcb5b7b590829d879b868db79b9999b49c868795da939b82"><span class="__cf_email__" data-cfemail="c18289808280a5b7a8b2aeb3b882aeacac81a9b3b2a0efa6aeb7">[email protected]</span></a>) prior
to and up to 10 business days after the meeting. Visit the meeting
information page for additional details: <a href="https://targethiv.org/events/chac">https://targethiv.org/events/chac</a>.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Breana Alsworth
(<a href="/cdn-cgi/l/email-protection#adeee5eceeecc9dbc4dec2dfd4eec2c0c0edc5dfdecc83cac2db"><span class="__cf_email__" data-cfemail="74373c35373510021d071b060d371b1919341c0607155a131b02">[email protected]</span></a>) at least 10 business days prior to the
meeting. Since this meeting occurs in a Federal Government building,
attendees must go through a security check to enter the building. Non-
U.S. Citizen attendees must notify HRSA of their planned attendance at
least 20 business days prior to the meeting to facilitate their entry
into the building. All attendees are required to present government-
issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-16504 Filed 7-25-24; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.